Publications
November 30, 2022
ADAI CERP Report to Legislature Details Public Health Risks for High-THC Cannabis
In early fall, ADAI Acting Associate Professor Beatriz Carlini, PhD, MPH and her team at the Cannabis Education & Research Program (CERP) published and delivered a report to the Washington State legislature that addresses the public health challenges of cannabis products with high concentrations of THC, the psychoactive ingredient in cannabis that causes a “high.”…
November 23, 2022
New from ADAI: Provider Perspectives on Medication Treatment for OUD in Adolescents
Despite recent surges in adolescent opioid use disorder (OUD), teens are less likely to enter treatment compared to adults, and are rarely in treatment settings that offer evidence-based medication treatment (methadone, buprenorphine, and naltrexone). Buprenorphine is the only medication approved for people under 18 (aged 16 and older) and methadone requires written parental consent for…
November 8, 2022
New ADAI Report: Overdose Deaths Involving Prescription Opioids in WA, 2010-2021
This new report by Caleb Banta-Green, PhD, MPH, MSW and Jason Williams, PhD of the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) examines key indicators related to pharmaceutical opioids including sales data and overdose death rates. Key Points Prescription opioid overdose deaths declined from their peak in 2006, but are higher than…
November 7, 2022
New Research from ADAI: Opioid Safety Intervention for Community Pharmacists
ADAI Research Associate Professor Anthony Floyd, PhD has a new paper out describing an assessment of community pharmacists’ readiness to implement an educational program that aims to boost their knowledge and confidence when it comes to providing opioid safety and harm reduction services to patients and customers. What is the context for this study? Community…
October 18, 2022
Virtual Training More Cost-Effective Than In-Person Training for Contingency Management
Contingency management (CM) is an evidence-based practice that uses behavioral reinforcement, like rewards, to shape client behavior toward a treatment goal, such as attending counseling sessions or abstinence. The intervention has been studied extensively in addiction treatment settings for half a century and found reliably effective in treatment of both opioid use disorder and methamphetamine…
August 2, 2022
Cannabis-Related Calls to the WA Poison Center, 2017-2021
The Washington Poison Center (WPC) receives calls for help about people who used a substance and experienced negative reactions. An increase in poison center calls for cannabis consumption has been documented in legalized states since 2014, including Washington. Given this increase and the diversification of legalized cannabis products, poison centers began collecting more information on…
August 1, 2022
How to Talk to Your Partner About Their Addiction (UW Right as Rain)
This piece from the UW Medicine magazine Right as Rain (by McKenna Princing) features advice from ADAI/Psychiatry Assistant Professor Mandy Owens, PhD on how couples can talk to each other about their substance use. The pandemic has led to worsened mental health for many folks, including an increase of use of substances to cope. “People…
July 22, 2022
New from ADAI: Most US Adults Who Use Cannabis Also Use Other Substances
This new article, coauthored by ADAI Research Scientists Beatriz Carlini, PhD, MPH and Gillian Schauer, PhD, MPH, reports on one of the first studies to explore the prevalence of adults in the U.S. who use cannabis while abstaining from other substances. Using data from adults aged 18 or older who responded to the 2017 or…
July 21, 2022
New: Cannabis Legalization in WA: Policy Evolution and Emerging Evidence from the First 9 Years
The new book THE CANNABIS SOCIAL CLUB (Routledge, 2023) features a chapter focused on policy evolution and emerging evidence from the first nine years of cannabis legalization in Washington state that was co-authored by Julia Dilley (Oregon Health Authority and UW), Caislin Firth (UW ADAI), and Beau Kilmer (RAND Corporation). The book’s title, “Cannabis Social…
July 13, 2022
New Article: Community-Based “Meds-First” Model of Care for Opioid Use Disorder Study
This paper, by ADAI Principal Research Scientist Caleb Banta-Green and colleagues, describes the Community-Based “Meds First” model of care for opioid use disorder treatment and an ongoing study. The Meds First model of care is based on same-day (typically) access to buprenorphine; walk-in, non-appointment support with a nurse care manager and care navigator; no…
Previous page Next page
